418 related articles for article (PubMed ID: 33167881)
1. Meta-analysis of metabolites involved in bioenergetic pathways reveals a pseudohypoxic state in Down syndrome.
Pecze L; Randi EB; Szabo C
Mol Med; 2020 Nov; 26(1):102. PubMed ID: 33167881
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of gene expression patterns in Down syndrome highlights significant alterations in mitochondrial and bioenergetic pathways.
Pecze L; Szabo C
Mitochondrion; 2021 Mar; 57():163-172. PubMed ID: 33412332
[TBL] [Abstract][Full Text] [Related]
3. Plasma metabolites related to cellular energy metabolism are altered in adults with Down syndrome and Alzheimer's disease.
Gross TJ; Doran E; Cheema AK; Head E; Lott IT; Mapstone M
Dev Neurobiol; 2019 Jul; 79(7):622-638. PubMed ID: 31419370
[TBL] [Abstract][Full Text] [Related]
4. Metabolic and Growth Rate Alterations in Lymphoblastic Cell Lines Discriminate Between Down Syndrome and Alzheimer's Disease.
Coskun P; Helguera P; Nemati Z; Bohannan RC; Thomas J; Samuel SE; Argueta J; Doran E; Wallace DC; Lott IT; Busciglio J
J Alzheimers Dis; 2017; 55(2):737-748. PubMed ID: 27802222
[TBL] [Abstract][Full Text] [Related]
5. Waves of gene regulation suppress and then restore oxidative phosphorylation in cancer cells.
Smolková K; Plecitá-Hlavatá L; Bellance N; Benard G; Rossignol R; Ježek P
Int J Biochem Cell Biol; 2011 Jul; 43(7):950-68. PubMed ID: 20460169
[TBL] [Abstract][Full Text] [Related]
6. Adaptive downregulation of mitochondrial function in down syndrome.
Helguera P; Seiglie J; Rodriguez J; Hanna M; Helguera G; Busciglio J
Cell Metab; 2013 Jan; 17(1):132-40. PubMed ID: 23312288
[TBL] [Abstract][Full Text] [Related]
7. Plasma metabolome and cognitive skills in Down syndrome.
Antonaros F; Ghini V; Pulina F; Ramacieri G; Cicchini E; Mannini E; Martelli A; Feliciello A; Lanfranchi S; Onnivello S; Vianello R; Locatelli C; Cocchi G; Pelleri MC; Vitale L; Strippoli P; Luchinat C; Turano P; Piovesan A; Caracausi M
Sci Rep; 2020 Jun; 10(1):10491. PubMed ID: 32591596
[TBL] [Abstract][Full Text] [Related]
8. A Novel Methodology for Bioenergetic Analysis of Plasmodium falciparum Reveals a Glucose-Regulated Metabolic Shift and Enables Mode of Action Analyses of Mitochondrial Inhibitors.
Sakata-Kato T; Wirth DF
ACS Infect Dis; 2016 Dec; 2(12):903-916. PubMed ID: 27718558
[TBL] [Abstract][Full Text] [Related]
9. Characterization of mitochondrial and metabolic alterations induced by trisomy 21 during neural differentiation.
Prutton KM; Marentette JO; Maclean KN; Roede JR
Free Radic Biol Med; 2023 Feb; 196():11-21. PubMed ID: 36638900
[TBL] [Abstract][Full Text] [Related]
10. Metabolic Infrastructure of Pregnant Women With Trisomy 21 Fetuses; Metabolomic Analysis.
Nemutlu E; Orgul G; Recber T; Aydin E; Ozkan E; Turgal M; Alikasifoglu M; Kir S; Beksac MS
Z Geburtshilfe Neonatol; 2019 Oct; 223(5):297-303. PubMed ID: 31132797
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial Dysfunction in Down Syndrome: From Pathology to Therapy.
Tan KL; Lee HC; Cheah PS; Ling KH
Neuroscience; 2023 Feb; 511():1-12. PubMed ID: 36496187
[TBL] [Abstract][Full Text] [Related]
12. Role of the cystathionine β-synthase / H
Panagaki T; Pecze L; Randi EB; Nieminen AI; Szabo C
Redox Biol; 2022 Sep; 55():102416. PubMed ID: 35921774
[TBL] [Abstract][Full Text] [Related]
13. Metabolomics profiling reveals differential adaptation of major energy metabolism pathways associated with autophagy upon oxygen and glucose reduction.
Weckmann K; Diefenthäler P; Baeken MW; Yusifli K; Turck CW; Asara JM; Behl C; Hajieva P
Sci Rep; 2018 Feb; 8(1):2337. PubMed ID: 29402948
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria as pharmacological targets in Down syndrome.
Valenti D; Braidy N; De Rasmo D; Signorile A; Rossi L; Atanasov AG; Volpicella M; Henrion-Caude A; Nabavi SM; Vacca RA
Free Radic Biol Med; 2018 Jan; 114():69-83. PubMed ID: 28838841
[TBL] [Abstract][Full Text] [Related]
15. Overproduction of H
Panagaki T; Randi EB; Augsburger F; Szabo C
Proc Natl Acad Sci U S A; 2019 Sep; 116(38):18769-18771. PubMed ID: 31481613
[TBL] [Abstract][Full Text] [Related]
16. Amniotic fluid and urine metabolomic alterations associated with pregnant women with Down syndrome fetuses.
Chen X; Hu L; Su J; Liu X; Luo X; Pei Y; Gao Y; Wei F
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7882-7889. PubMed ID: 34130603
[TBL] [Abstract][Full Text] [Related]
17. Plasma and urinary metabolomic profiles of Down syndrome correlate with alteration of mitochondrial metabolism.
Caracausi M; Ghini V; Locatelli C; Mericio M; Piovesan A; Antonaros F; Pelleri MC; Vitale L; Vacca RA; Bedetti F; Mimmi MC; Luchinat C; Turano P; Strippoli P; Cocchi G
Sci Rep; 2018 Feb; 8(1):2977. PubMed ID: 29445163
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Drp1-mediated mitochondrial fission improves mitochondrial dynamics and bioenergetics stimulating neurogenesis in hippocampal progenitor cells from a Down syndrome mouse model.
Valenti D; Rossi L; Marzulli D; Bellomo F; De Rasmo D; Signorile A; Vacca RA
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3117-3127. PubMed ID: 28939434
[TBL] [Abstract][Full Text] [Related]
19. Serum metabolomic profiling in acute alcoholic hepatitis identifies multiple dysregulated pathways.
Rachakonda V; Gabbert C; Raina A; Bell LN; Cooper S; Malik S; Behari J
PLoS One; 2014; 9(12):e113860. PubMed ID: 25461442
[TBL] [Abstract][Full Text] [Related]
20. Metabolic profiling and flux analysis of MEL-2 human embryonic stem cells during exponential growth at physiological and atmospheric oxygen concentrations.
Turner J; Quek LE; Titmarsh D; Krömer JO; Kao LP; Nielsen L; Wolvetang E; Cooper-White J
PLoS One; 2014; 9(11):e112757. PubMed ID: 25412279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
